Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6


Pharmacokinetics, safety and efficacy of an allometric miltefosine regimen for the treatment of visceral leishmaniasis in Eastern African children: an open-label, phase-II clinical trial.

Mbui J, Olobo J, Omollo R, Solomos A, Kip AE, Kirigi G, Sagaki P, Kimutai R, Were L, Omollo T, Egondi TW, Wasunna M, Alvar J, Dorlo TPC, Alves F.

Clin Infect Dis. 2018 Sep 5. doi: 10.1093/cid/ciy747. [Epub ahead of print]


Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives.

Alves F, Bilbe G, Blesson S, Goyal V, Monnerat S, Mowbray C, Muthoni Ouattara G, P├ęcoul B, Rijal S, Rode J, Solomos A, Strub-Wourgaft N, Wasunna M, Wells S, Zijlstra EE, Arana B, Alvar J.

Clin Microbiol Rev. 2018 Aug 29;31(4). pii: e00048-18. doi: 10.1128/CMR.00048-18. Print 2018 Oct. Review.


Activation and Regulation of B Cell Responses by Invariant Natural Killer T Cells.

Doherty DG, Melo AM, Moreno-Olivera A, Solomos AC.

Front Immunol. 2018 Jun 18;9:1360. doi: 10.3389/fimmu.2018.01360. eCollection 2018. Review.


CD4+ T cells require either B cells or CD8+ T cells to control spread and pathogenesis of a neurotropic infection.

Solomos AC, O'Regan KJ, Rall GF.

Virology. 2016 Dec;499:196-202. doi: 10.1016/j.virol.2016.09.013. Epub 2016 Sep 24.


Get It through Your Thick Head: Emerging Principles in Neuroimmunology and Neurovirology Redefine Central Nervous System "Immune Privilege".

Solomos AC, Rall GF.

ACS Chem Neurosci. 2016 Apr 20;7(4):435-41. doi: 10.1021/acschemneuro.5b00336. Epub 2016 Feb 18. Review.


Extended JAK activation and delayed STAT1 dephosphorylation contribute to the distinct signaling profile of CNS neurons exposed to interferon-gamma.

Podolsky MA, Solomos AC, Durso LC, Evans SM, Rall GF, Rose RW.

J Neuroimmunol. 2012 Oct 15;251(1-2):33-8. doi: 10.1016/j.jneuroim.2012.06.006. Epub 2012 Jul 4.

Supplemental Content

Loading ...
Support Center